Europe Archives - Page 74 of 93 - Journal for Clinical Studies

Current Edition

Asia Pacific

Pelican BioThermal To Open New Tokyo Service Center

New location to service rapidly expanding Crēdo™ on Demand rental program Pelican BioThermal, the global name in temperature controlled packaging, announces th...

4 April 2018 Asia Pacific | Europe biothermal | center

Continue Reading →

Asia Pacific

Esco, Max Planck cooperate on research of flavivirus vaccines

The purpose of the project is to culture Vero cells, using a packed bed bioreactor to a high cell density, and produce live attenuated yellow fever virus (YFV). Esco ...

4 April 2018 Asia Pacific | Europe Esco | flavivirus

Continue Reading →

Europe

Immunovaccine Announces Initiation of Patient Dosing in Investigator-Sponsored Phase 2 Clinical Trial of Its Lead Candidate DPX-Survivac Used in Combination with Pembrolizumab in Patients with DLBCL

Immunovaccine Inc., a clinical stage immuno-oncology company, today announced that the first patient has been treated in a Phase 2 Study combining DPX-Survivac with L...

28 March 2018 Europe DLBCL | Immunovaccine

Continue Reading →

Europe

Paradigm Biopharma’s clinical trials in the fast lane

Paradigm Biopharmaceuticals (ASX: PAR) is surpassing its own expectations in recruiting patients for its two phase two clinical trials, which will speed up the announ...

28 March 2018 Europe | North America biopharma | clinical

Continue Reading →

Europe

miRagen Announces Initiation of Phase 1 Clinical Trial of MRG-110

miRagen Therapeutics, Inc, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today the initiati...

28 March 2018 Europe | North America clinical | miRagen

Continue Reading →

Europe

Syneos Health Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution

Syneos Health™, the only fully integrated biopharmaceutical solutions organization, today announced that the company is a founding member of Align Clinical CRO. This ...

28 March 2018 Europe | North America Align | clinical

Continue Reading →

Europe

Clinical Trial Access to Expand Following Receipt of Additional Funding

Elligo Health Research receives $16 million to expand its programs. Austin, Texas-based Elligo Health Research is a company focused on expanded access to clinical tri...

28 March 2018 Europe clinical trials | Elligo Health Research

Continue Reading →

Europe

TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn’s disease in Europe

First allogeneic stem cell therapy to receive central marketing authorization approval in Europe Alofisel offers a new treatment option for patients who d...

28 March 2018 Europe Alofisel | approved

Continue Reading →

Asia Pacific

Shionogi to Modernize Product Quality Management in the Cloud with Veeva Vault QMS

Pharmaceutical company in Japan unifies product quality management processes across global stakeholders Veeva Systems today announced that Shionogi & Co., Ltd., a...

28 March 2018 Asia Pacific | Europe management | product

Continue Reading →

Europe

Polyphor announces enrollment of first patient in Phase III clinical trial for murepavadin – a pathogen-specific antibiotic being developed for the treatment of nosocomial pneumonia

Potentially first new class of antibiotics in Phase III development against Gramnegative pathogens in 50 years Polyphor today announced the enrollment of the first pa...

28 March 2018 Europe clinical | patient

Continue Reading →